companies

Oxford VR

Founded 2016
Employees 10+
Primary contact
31-35 Kirby Street
EC1N 8TE London
United Kingdom
Links
https://oxfordvr.co/
Sections
Technologies
A spin-out from Oxford University, Oxford VR is developing VR-based clinically validated, cost-effective, user-centered mental health treatments that are faster and more effective than traditional treatments while significantly lowering the cost to health providers. Oxford VR's first product, an automated VR treatment for psychosis, was tested in a large randomized controlled trial, with the results gaining global acclaim in the Lancet Psychiatry. The treatment is now being used in select NHS clinics.  The second treatment, Social Engagement, is a mental health intervention that uses VR to help individuals overcome anxious social avoidance. It is available in the UK to NHS patients via providers of NHS Improving Access to Psychological Therapies and other UK mental healthcare providers.
Select partners: NHS, AXA, The Chinese University of Hong Kong (CUHK), Universal Health Services (UHS), Eliot Community Human Services, Wounded Warrior Project, National Mental Health Innovation Center, McPin Foundation.
Founded 2016
Employees 10+
Primary contact
31-35 Kirby Street
EC1N 8TE London
United Kingdom
Links
https://oxfordvr.co/
Sections
Technologies

Funding 💰

Total $17.2M
Select investors Optum Ventures, Oxford Sciences Innovation, University of Oxford, GT Healthcare Capital Partners, Luminous Ventures, Force Over Mass, RT Capital

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Hot market & tech: Treating mental health with digital tools is a growing market, and so is the use of virtual reality (and other extended reality technologies) in healthcare.
  • Solves a problem: By transforming mental healthcare with the help of VR, OxfordVR is effectively expanding access and easing the strain on overloaded providers.
  • A science-backed enterprise: OxfordVR's treatments are built on more than 25 years of research into the mechanisms driving mental illness from Scientific Co-Founder Daniel Freeman and his team at Oxford University.
  • It works: OxfordVR conducted a 350-patient clinical trial, published in Lancet Psychiatry, showing positive effects in psychosis patients — reducing avoidance, distress, and paranoia. 🔗
  • Already available: The company's Social engagement product is readily available to NHS patients via providers of NHS Improving Access to Psychological Therapies and other UK mental healthcare providers. 🔗

Video ▶️

Awards & Recognitions 🏆

  • 2020 UK Digital Experience Awards: GOLD in the category Best Use of Emerging Technology 🔗
  • 2020 Med-Tech Innovation Awards: Finalist 🔗
  • 2019 Go:Tech Awards - Winner of Best Use of VR/AR 🔗
  • 2019 European Lifestars Awards: Finalist 🔗
  • 2019 BIMA Awards: Finalist 🔗
  • 2019 UK Digital Experience Awards: Winner of Best Use of Emerging Technology 🔗
  • 2019 Mayor of London's Med Tech awards: Finalist 🔗
  • 2019 - One of 10 European VR startups to look out for 🔗
Last update: August 14, 2022